idw – Informationsdienst Wissenschaft

Nachrichten, Termine, Experten

Grafik: idw-Logo
Grafik: idw-Logo

idw - Informationsdienst
Wissenschaft

Science Video Project
idw-Abo

idw-News App:

AppStore

Google Play Store



Instanz:
Teilen: 
24.09.2024 11:28

From Molecule to Disease: PIPs Project of the Leibniz Cooperative Excellence Launched

Silke Oßwald Presse- und Öffentlichkeitsarbeit
Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)

    What role do certain lipids, known as phosphoinositides (PIPs), play in obesity and other metabolic diseases? This is now being investigated by scientists from the Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP) in Berlin, the German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE), and the Leibniz-Institut für Analytische Wissenschaften (ISAS) in a joint project.

    The FMP, DIfE and ISAS have raised almost one million euros from the Leibniz Association as part of the “Leibniz Cooperative Excellence” program, in order to study the role of phosphoinositides in a healthy organism and in metabolic diseases such as type 2 diabetes in more detail. The project will focus on a key aspect: it is assumed that these phospholipids transmit vital, food-dependent signals to cells and organs, such as whether the body is full or hungry, or whether it should switch to anabolic (building up) or catabolic (breaking down) metabolism. "We believe that PIPs play a key role in communication between cells, but how these processes work is barely understood," says project leader and FMP director Prof. Dr. Volker Haucke.

    Impaired metabolism due to altered PIP signaling?
    The starting point for the project were investigations into a genetic muscle development disorder. FMP researchers showed that due to a missing or malfunctioning lipid phosphatase, fats could not be incorporated into the metabolism of mitochondria — the cell's powerhouses. This rare genetic disease leads to death in childhood. Meanwhile, DIfE had linked the same gene to obesity. The researchers now aim to examine whether a shared fundamental mechanism — possibly altered PIP signaling — underlies both extremes, and to test additional hypotheses. "We research from molecule to disease," emphasizes Volker Haucke, "because we want to understand what changes in metabolism occur depending on food availability."

    New analytical methods to decode signaling pathways
    While FMP focuses on the molecular and cellular level, DIfE will conduct preclinical studies using two mouse models. ISAS, in turn, is responsible for developing the missing PIP analysis methods. The researchers will first create mass spectrometry methods to analyze the frequency and identity of PIPs in cells and tissues, for instance. "So far, the lack of analytics has hindered a better understanding of PIP signaling pathways," explains Prof. Dr. Sven Heiles, head of the Lipidomics research group at ISAS. Applying theirnew analytical techniques, the scientists aim to investigate the physiological role of changes in cellular PIP levels due to changes in nutrient supply in selected cell systems. The consortium will then use these findings to further study PIP metabolism in mouse models under normal and increased nutrient supply conditions.
    "We are aware that we are dealing with very complex questions here," says Prof. Dr. Annette Schürmann from DIfE. "But we hope that this project will help us understand molecular processes following fasting and food intake and, in the long term, assist many people with obesity."

    The PIPMet project "Phosphoinositide-mediated nutrient response in metabolic disease" has started in February this year and is expected to run until July 2027. Both early-career and experienced researchers are involved.

    Episode on the topic in the Wirkstoffradio
    More information about the project is available in the podcast with Prof. Dr. Volker Haucke and Bernd Rupp. www.wirkstoffradio.de, Episode: WSR078 Phosphoinositide bei Stoffwechselkrankheiten PIPMet – Interview mit Prof. Dr. Volker Haucke. The interview was conducted in German.
    https://www.wirkstoffradio.de/2024/08/04/wsr078-phosphoinositide-bei-stoffwechse...


    Wissenschaftliche Ansprechpartner:

    Prof. Dr. Volker Haucke
    Research Unit Molecular Pharmacology and Cell Biology
    Leibniz-Forschungsinstitut für Molekulare Pharmakologie (FMP)
    haucke@fmp-berlin.de
    Phone.: +49 30 94793 100


    Weitere Informationen:

    http://More information about the project is available in the podcast with Prof. Dr. Volker Haucke and Bernd Rupp. www.wirkstoffradio.de, Episode: WSR078 Phosphoinositide bei Stoffwechselkrankheiten PIPMet – Interview mit Prof. Dr. Volker Haucke. The interview was conducted in German.
    https://www.wirkstoffradio.de/2024/08/04/wsr078-phosphoinositide-bei-stoffwechse...


    Bilder

    Biological samples are taken from a nitrogen tank.
    Biological samples are taken from a nitrogen tank.
    D. Ausserhofer
    DIfE, D. Ausserhofer


    Merkmale dieser Pressemitteilung:
    Journalisten, Studierende, Wissenschaftler
    Biologie, Chemie, Medizin
    überregional
    Forschungsprojekte, Kooperationen
    Englisch


     

    Hilfe

    Die Suche / Erweiterte Suche im idw-Archiv
    Verknüpfungen

    Sie können Suchbegriffe mit und, oder und / oder nicht verknüpfen, z. B. Philo nicht logie.

    Klammern

    Verknüpfungen können Sie mit Klammern voneinander trennen, z. B. (Philo nicht logie) oder (Psycho und logie).

    Wortgruppen

    Zusammenhängende Worte werden als Wortgruppe gesucht, wenn Sie sie in Anführungsstriche setzen, z. B. „Bundesrepublik Deutschland“.

    Auswahlkriterien

    Die Erweiterte Suche können Sie auch nutzen, ohne Suchbegriffe einzugeben. Sie orientiert sich dann an den Kriterien, die Sie ausgewählt haben (z. B. nach dem Land oder dem Sachgebiet).

    Haben Sie in einer Kategorie kein Kriterium ausgewählt, wird die gesamte Kategorie durchsucht (z.B. alle Sachgebiete oder alle Länder).